The group’s principle activities include developing, manufacturing and distributing reagents for infectious disease agents. The group’s products include Hexaplex(R), Hexaplex(R) Plus, ProFlu-1(TM), ProFlu-2(TM), ProhMPV(TM), ProParaflu(TM) and ProRSV(TM). The group operates from United States.